Пеметрексед Канон - analogs
Components: Pemetrexed |
|||||||||
Pharmgroups: Antimetabolites || Folic acid analogues |
|||||||||
| Prices in pharmacies: — Instructions Пеметрексед Канон | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Algeldrate ✘ (incl) Rebamipide ✘ (incl) Комплекс с пектином ЖИДКИЙ УГОЛЬ для детей ✘ (incl) Elaps corallinus ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
| ≈100% | Pemetrexed neutral | 407.7€ |
| ≈100% | Alimta neutral | 447.2-480€ |
| ≈100% | Pemetrexed-nativ neutral | — |
| ≈100% | Pemetrexed-TL neutral | — |
| ≈100% | Pemetrexed disodium neutral | — |
| ≈100% | Pemetrexed J neutral | — |
| ≈100% | Verotrexed neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% 838€ Tarceva neutral [Erlotinib]
- 45% — Лорвиква neutral [Lorlatinib]
- 45% — Erlotinib - native neutral [Erlotinib]
- 45% 2103.9€ Mekinist neutral [Trametinib]
- 44% 2535.2€ Alecensa neutral [Alectinib]
- 44% — Tarlenib neutral [Erlotinib]
- 40% — Vinorelbine medac neutral [Vinorelbine]
- 40% — Erlotinib neutral [Erlotinib]
- 40% — Vinorelbine bitartrate neutral [Vinorelbine]
- 40% — Vinorelbine tartrate neutral [Vinorelbine]
- 40% 9.4-25.8€ Vinelbine neutral [Vinorelbine]
- 40% — Vincarelbine neutral [Vinorelbine]
- 40% — Tomudex neutral [Raltitrexed]
- 37% 250-450€ Opdivo neutral [Nivolumab]
- 37% 46.5€ Maverex neutral [Vinorelbine]
- 37% 15.5-57.5€ Cytuvin neutral [Vinorelbine]
- 37% 32.3-50.9€ Navelbine neutral [Vinorelbine]
- 37% 4-22.5€ Vinorelbine -Teva neutral [Vinorelbine]
- 35% — Эрлотиниб-тл neutral [Erlotinib]
- 34% 40€ Velbin neutral [Vinorelbine]
- 34% — Vinorelbine Kelun-Kazpharm neutral [Vinorelbine]
- 32% — Осимертиниб neutral [Osimertinib]
- 32% — Осимертиниба мезилат neutral [Osimertinib]
- 32% 5550€ Tagrisso neutral [Osimertinib]
- 31% — Vinorelbine neutral [Vinorelbine]
- 31% — Vincatera neutral [Vinorelbine]
- 30% — Пемброриа neutral [Pembrolizumab]
- 29% 1114€ Iressa Negative 🔍 [Gefitinib]
- 29% — Zykadia Negative 🔍 [Ceritinib]
- 29% — Gefitinib Negative 🔍 [Gefitinib]
- 25% 637.5-902.1€ Giotrif neutral [Afatinib]
- 24% 862.9€ Vargatef neutral [Nintedanib]
- 22% — Gemcitera neutral [Gemcitabine]
- 22% 26.2-41.9€ Gemcitabine medac neutral [Gemcitabine]
- 22% 22.5€ Gemita neutral [Gemcitabine]
- 22% 9-49€ Gemzar neutral [Gemcitabine]
- 22% — Gemtaz neutral [Gemcitabine]
- 22% 19.6€ Gemcitabine-Teva neutral [Gemcitabine]
- 22% 12.5-59.4€ Gemcitare neutral [Gemcitabine]
- 22% — Gemcitabine hydrochloride neutral [Gemcitabine]
- 22% — Gemcitabine-Rus neutral [Gemcitabine]
- 22% — Gemcex neutral [Gemcitabine]
- 22% 66.6€ Gemcitover neutral [Gemcitabine]
- 22% 6.8-32€ Cytogem neutral [Gemcitabine]
- 22% — Gemcitabine Actavis neutral [Gemcitabine]
- 22% — Гемцитабин - Келун - Казфарм neutral [Gemcitabine]
- 22% — Гемцитабин-промомед neutral [Gemcitabine]
- 22% — Gemcitabine Pliva neutral [Gemcitabine]
- 22% 3.5-16.8€ Gemcitabine-Ebewe neutral [Gemcitabine]
- 21% 9.2-23€ Ongecin neutral [Gemcitabine]
Learn more about the selection of analogues
- The drug has «Пеметрексед Канон» 18 full analogs, the cheapest - Пемелан (76.2-377.7€); 51 analog by action, the most similar - Tarceva (838€).
- Medical online service has selected the best substitutes for Пеметрексед Канон based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Пеметрексед Канон analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.